 Allison Blackmer
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parenteral Nutrition | 9 | 2023 | 92 | 2.180 |
Why?
| | Education, Pharmacy | 5 | 2018 | 130 | 1.970 |
Why?
| | Faculty, Pharmacy | 4 | 2017 | 17 | 1.550 |
Why?
| | Schools, Pharmacy | 4 | 2017 | 52 | 1.540 |
Why?
| | Career Mobility | 4 | 2017 | 66 | 1.500 |
Why?
| | Fat Emulsions, Intravenous | 3 | 2015 | 31 | 1.490 |
Why?
| | Pharmacists | 5 | 2017 | 238 | 1.400 |
Why?
| | Career Choice | 4 | 2017 | 192 | 1.340 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 116 | 1.220 |
Why?
| | Malnutrition | 5 | 2023 | 66 | 0.840 |
Why?
| | Cannabidiol | 2 | 2022 | 53 | 0.830 |
Why?
| | Nervous System Diseases | 2 | 2021 | 261 | 0.800 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 736 | 0.790 |
Why?
| | Clostridium Infections | 1 | 2021 | 57 | 0.770 |
Why?
| | Cholestasis | 2 | 2014 | 228 | 0.760 |
Why?
| | Motor Disorders | 1 | 2020 | 16 | 0.750 |
Why?
| | Muscle Spasticity | 1 | 2020 | 53 | 0.720 |
Why?
| | Cerebral Palsy | 1 | 2020 | 80 | 0.690 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2019 | 16 | 0.670 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 58 | 0.670 |
Why?
| | Parenteral Nutrition Solutions | 2 | 2015 | 2 | 0.640 |
Why?
| | Disabled Persons | 1 | 2020 | 147 | 0.640 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 120 | 0.610 |
Why?
| | Professional Competence | 1 | 2017 | 91 | 0.590 |
Why?
| | Medication Adherence | 1 | 2021 | 556 | 0.570 |
Why?
| | Teaching | 1 | 2018 | 236 | 0.560 |
Why?
| | Educational Measurement | 1 | 2018 | 289 | 0.560 |
Why?
| | Enteral Nutrition | 5 | 2023 | 170 | 0.550 |
Why?
| | Chronic Disease | 2 | 2021 | 1636 | 0.550 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 241 | 0.530 |
Why?
| | Selenium | 1 | 2015 | 38 | 0.520 |
Why?
| | Trace Elements | 1 | 2015 | 46 | 0.500 |
Why?
| | Empyema, Pleural | 1 | 2014 | 11 | 0.480 |
Why?
| | Pleural Effusion | 1 | 2014 | 47 | 0.470 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 60 | 0.450 |
Why?
| | Central Nervous System | 1 | 2014 | 245 | 0.430 |
Why?
| | Pediatrics | 4 | 2021 | 985 | 0.430 |
Why?
| | Copper | 1 | 2012 | 102 | 0.420 |
Why?
| | Tissue Plasminogen Activator | 1 | 2014 | 231 | 0.410 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 238 | 0.400 |
Why?
| | Cross Infection | 1 | 2013 | 205 | 0.400 |
Why?
| | Laxatives | 1 | 2010 | 18 | 0.380 |
Why?
| | Dietary Fiber | 1 | 2010 | 44 | 0.380 |
Why?
| | Child | 12 | 2023 | 19129 | 0.370 |
Why?
| | Constipation | 1 | 2010 | 76 | 0.360 |
Why?
| | Hospitalization | 2 | 2021 | 1785 | 0.360 |
Why?
| | Humans | 34 | 2023 | 118974 | 0.350 |
Why?
| | Polysaccharides | 1 | 2009 | 78 | 0.340 |
Why?
| | Pneumonia | 1 | 2014 | 592 | 0.320 |
Why?
| | Thrombocytopenia | 1 | 2009 | 185 | 0.310 |
Why?
| | Students, Pharmacy | 2 | 2018 | 99 | 0.300 |
Why?
| | Child, Preschool | 6 | 2021 | 9491 | 0.290 |
Why?
| | Nutritional Support | 4 | 2022 | 28 | 0.280 |
Why?
| | Professional Role | 2 | 2017 | 153 | 0.280 |
Why?
| | Infant | 6 | 2021 | 8293 | 0.280 |
Why?
| | Anticoagulants | 1 | 2009 | 559 | 0.260 |
Why?
| | Nutrition Disorders | 1 | 2023 | 23 | 0.240 |
Why?
| | Food, Formulated | 1 | 2023 | 19 | 0.240 |
Why?
| | Dietetics | 1 | 2023 | 22 | 0.230 |
Why?
| | Infant, Newborn | 4 | 2015 | 5255 | 0.210 |
Why?
| | Epilepsies, Myoclonic | 1 | 2022 | 42 | 0.210 |
Why?
| | Nutrition Therapy | 1 | 2022 | 32 | 0.210 |
Why?
| | Pharmaceutical Services | 1 | 2022 | 79 | 0.200 |
Why?
| | Public-Private Sector Partnerships | 1 | 2021 | 43 | 0.200 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 12 | 0.190 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 54 | 0.190 |
Why?
| | Vancomycin | 1 | 2021 | 79 | 0.190 |
Why?
| | United States | 9 | 2023 | 12555 | 0.190 |
Why?
| | Medication Therapy Management | 1 | 2020 | 72 | 0.180 |
Why?
| | Symptom Assessment | 1 | 2020 | 123 | 0.180 |
Why?
| | Analgesics | 1 | 2020 | 159 | 0.170 |
Why?
| | Health Personnel | 2 | 2023 | 588 | 0.170 |
Why?
| | Preceptorship | 1 | 2018 | 63 | 0.160 |
Why?
| | Employee Performance Appraisal | 1 | 2017 | 5 | 0.160 |
Why?
| | Faculty | 1 | 2018 | 135 | 0.150 |
Why?
| | Feedback | 1 | 2017 | 153 | 0.150 |
Why?
| | Male | 7 | 2021 | 57801 | 0.150 |
Why?
| | Medicare | 1 | 2022 | 663 | 0.140 |
Why?
| | Female | 7 | 2021 | 61565 | 0.140 |
Why?
| | Adolescent | 3 | 2021 | 18480 | 0.140 |
Why?
| | Adult | 5 | 2023 | 31512 | 0.130 |
Why?
| | Electrolytes | 1 | 2015 | 59 | 0.130 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 4708 | 0.130 |
Why?
| | Nutritionists | 1 | 2014 | 11 | 0.130 |
Why?
| | Soybean Oil | 1 | 2014 | 12 | 0.130 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 136 | 0.130 |
Why?
| | Academies and Institutes | 1 | 2014 | 44 | 0.120 |
Why?
| | Societies, Medical | 1 | 2018 | 703 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4552 | 0.120 |
Why?
| | Vitamins | 1 | 2015 | 158 | 0.120 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2015 | 131 | 0.110 |
Why?
| | Parents | 1 | 2020 | 1212 | 0.110 |
Why?
| | Biomedical Research | 1 | 2018 | 612 | 0.110 |
Why?
| | Curriculum | 1 | 2018 | 910 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1510 | 0.100 |
Why?
| | Clinical Competence | 1 | 2018 | 951 | 0.100 |
Why?
| | Amino Acids | 1 | 2015 | 465 | 0.100 |
Why?
| | Infant, Premature, Diseases | 1 | 2012 | 93 | 0.100 |
Why?
| | Young Adult | 2 | 2019 | 10793 | 0.100 |
Why?
| | Nutritional Status | 2 | 2023 | 300 | 0.100 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1129 | 0.090 |
Why?
| | Survival Analysis | 1 | 2013 | 1267 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2014 | 9342 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1945 | 0.090 |
Why?
| | Glucose | 1 | 2015 | 953 | 0.090 |
Why?
| | Quality of Life | 1 | 2020 | 2366 | 0.090 |
Why?
| | Logistic Models | 1 | 2014 | 1901 | 0.090 |
Why?
| | Infant, Premature | 1 | 2012 | 480 | 0.080 |
Why?
| | Child Welfare | 1 | 2010 | 199 | 0.080 |
Why?
| | Critical Illness | 1 | 2013 | 662 | 0.080 |
Why?
| | Heparin | 1 | 2009 | 230 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2015 | 12978 | 0.080 |
Why?
| | Incidence | 1 | 2013 | 2424 | 0.070 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1440 | 0.070 |
Why?
| | Risk Assessment | 1 | 2015 | 3057 | 0.070 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 969 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1816 | 0.060 |
Why?
| | Societies | 1 | 2023 | 42 | 0.060 |
Why?
| | Age Factors | 1 | 2010 | 2995 | 0.060 |
Why?
| | Algorithms | 1 | 2010 | 1541 | 0.060 |
Why?
| | Prospective Studies | 1 | 2014 | 6471 | 0.060 |
Why?
| | Fenfluramine | 1 | 2022 | 13 | 0.060 |
Why?
| | Nutrition Assessment | 1 | 2023 | 78 | 0.060 |
Why?
| | Drug Storage | 1 | 2022 | 59 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6561 | 0.050 |
Why?
| | Drug Stability | 1 | 2022 | 153 | 0.050 |
Why?
| | Epileptic Syndromes | 1 | 2022 | 63 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2022 | 175 | 0.050 |
Why?
| | Spasms, Infantile | 1 | 2022 | 104 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2022 | 184 | 0.050 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 44 | 0.050 |
Why?
| | Aged | 2 | 2022 | 19657 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 167 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2021 | 151 | 0.050 |
Why?
| | Temperature | 1 | 2022 | 622 | 0.040 |
Why?
| | Seizures | 1 | 2022 | 345 | 0.040 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 117 | 0.040 |
Why?
| | Research | 1 | 2021 | 411 | 0.040 |
Why?
| | Work | 1 | 2017 | 18 | 0.040 |
Why?
| | Time Management | 1 | 2017 | 16 | 0.040 |
Why?
| | Health Care Costs | 1 | 2021 | 394 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 658 | 0.040 |
Why?
| | Patient Care Team | 1 | 2022 | 521 | 0.040 |
Why?
| | Occupational Stress | 1 | 2017 | 34 | 0.040 |
Why?
| | Precision Medicine | 1 | 2021 | 363 | 0.040 |
Why?
| | Hospitals | 1 | 2021 | 598 | 0.040 |
Why?
| | Length of Stay | 1 | 2021 | 1032 | 0.040 |
Why?
| | Intestinal Diseases | 1 | 2016 | 30 | 0.040 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 193 | 0.040 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2016 | 98 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1153 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 170 | 0.030 |
Why?
| | History, 20th Century | 1 | 2016 | 281 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 796 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2017 | 408 | 0.030 |
Why?
| | Pain | 1 | 2020 | 735 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 345 | 0.030 |
Why?
| | Middle Aged | 1 | 2013 | 27617 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 963 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2674 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1185 | 0.030 |
Why?
| | Colorado | 1 | 2020 | 4196 | 0.020 |
Why?
|
|
Blackmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|